A Study to Assess PV-10 Chemoablation of Cancer of the Liver
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: Cancer Metastatic to the Liver|Hepatocellular Carcinoma|Metastatic Melanoma|Metastatic Ocular Melanoma|Metastatic Uveal Melanoma|Metastatic Lung Cancer|Metastatic Colon Cancer|Metastatic Colorectal Cancer|Metastatic Breast Cancer|Metastatic Pancreatic Cancer
Interventions: DRUG: PV-10 (10% rose bengal disodium)
Sponsor: Provectus Biopharmaceuticals, Inc.